163 related articles for article (PubMed ID: 3087670)
1. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
[TBL] [Abstract][Full Text] [Related]
3. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
Johnston CC; Altman RD; Canfield RE; Finerman GA; Taulbee JD; Ebert ML
Clin Orthop Relat Res; 1983; (172):186-94. PubMed ID: 6401608
[No Abstract] [Full Text] [Related]
4. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
Stein I; Shapiro B; Ostrum B; Beller ML
Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
[TBL] [Abstract][Full Text] [Related]
5. [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate].
Pinel B; Cambon C; Thomine JM; Cauvin M; Daragon A; Deshayes P
Rev Rhum Mal Osteoartic; 1984; 51(7-8):417-8. PubMed ID: 6436959
[No Abstract] [Full Text] [Related]
6. The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
Ralston SH; Boyce BF; Cowan RA; Fogelman I; Smith ML; Jenkins A; Boyle IT
J Bone Miner Res; 1987 Feb; 2(1):5-12. PubMed ID: 3137773
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).
Eyres KS; Marshall P; McCloskey E; Douglas DL; Kanis JA
Drug Saf; 1992; 7(2):162-5. PubMed ID: 1605902
[TBL] [Abstract][Full Text] [Related]
8. [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate].
Ravault A; Meunier PJ
Rev Rhum Mal Osteoartic; 1989 Mar; 56(4):293-302. PubMed ID: 2496461
[TBL] [Abstract][Full Text] [Related]
9. Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease.
Labinson P; Taxel P
Conn Med; 2007 May; 71(5):269-73. PubMed ID: 17526382
[No Abstract] [Full Text] [Related]
10. Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
Hoppé E; Masson C; Laffitte A; Chappard D; Audran M
Morphologie; 2012 Aug; 96(313):40-3. PubMed ID: 23022200
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
[TBL] [Abstract][Full Text] [Related]
12. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
Sieghart S
Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
[TBL] [Abstract][Full Text] [Related]
13. Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.
Basle MF; Rebel A; Renier JC; Audran M; Filmon R; Malkani K
Clin Orthop Relat Res; 1984 Apr; (184):281-8. PubMed ID: 6423333
[TBL] [Abstract][Full Text] [Related]
14. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results.
Khairi MR; Altman RD; DeRosa GP; Zimmermann J; Schenk RK; Johnston CC
Ann Intern Med; 1977 Dec; 87(6):656-63. PubMed ID: 412450
[TBL] [Abstract][Full Text] [Related]
15. [Pseudosarcomatous osteolysis in a Paget's disease patient treated with disodium etidronate (EHDP)].
Rondier J; Huchet B; Cayla J
Rev Rhum Mal Osteoartic; 1984 Jan; 51(1):49-54. PubMed ID: 6420876
[No Abstract] [Full Text] [Related]
16. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
De Vries HR; Bijvoet OL
Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
[No Abstract] [Full Text] [Related]
17. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
[TBL] [Abstract][Full Text] [Related]
18. Disodium etidronate (EHDP).
Evans RA
Med J Aust; 1984 Feb; 140(3):182-3. PubMed ID: 6420653
[No Abstract] [Full Text] [Related]
19. [Paget's disease: errors to be avoided].
Fournié A; Fournié B; Lassoued S
Rev Prat; 1989 Apr; 39(13):1143-6. PubMed ID: 2499920
[TBL] [Abstract][Full Text] [Related]
20. [Evolution of Paget's disease of bone during and after treatment with small doses of disodium etidronate (EHDP)].
Reginster JY; Gritten C; Diverse P; Hauwaert C; Halleux R; Franchimont P
Rev Med Liege; 1985 May; 40(10):417-22. PubMed ID: 3927462
[No Abstract] [Full Text] [Related]
[Next] [New Search]